Shanghai Xuerong BiotechnologyLtd Balance Sheet Health
Financial Health criteria checks 0/6
Shanghai Xuerong BiotechnologyLtd has a total shareholder equity of CN¥1.3B and total debt of CN¥2.5B, which brings its debt-to-equity ratio to 193.6%. Its total assets and total liabilities are CN¥4.7B and CN¥3.4B respectively.
Key information
193.6%
Debt to equity ratio
CN¥2.52b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥388.89m |
| Equity | CN¥1.30b |
| Total liabilities | CN¥3.40b |
| Total assets | CN¥4.70b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 300511's short term assets (CN¥897.5M) do not cover its short term liabilities (CN¥1.7B).
Long Term Liabilities: 300511's short term assets (CN¥897.5M) do not cover its long term liabilities (CN¥1.7B).
Debt to Equity History and Analysis
Debt Level: 300511's net debt to equity ratio (163.7%) is considered high.
Reducing Debt: 300511's debt to equity ratio has increased from 87.1% to 193.6% over the past 5 years.
Debt Coverage: 300511's debt is not well covered by operating cash flow (7.7%).
Interest Coverage: Insufficient data to determine if 300511's interest payments on its debt are well covered by EBIT.